Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Publisher Correction: Genomic insights into the 2016-2017 cholera epidemic in Yemen.

Weill FX, Domman D, Njamkepo E, Almesbahi AA, Naji M, Nasher SS, Rakesh A, Assiri AM, Sharma NC, Kariuki S, Pourshafie MR, Rauzier J, Abubakar A, Carter JY, Wamala JF, Seguin C, Bouchier C, Malliavin T, Bakhshi B, Abulmaali HHN, Kumar D, Njoroge SM, Malik MR, Kiiru J, Luquero FJ, Azman AS, Ramamurthy T, Thomson NR, Quilici ML.

Nature. 2019 Feb;566(7745):E14. doi: 10.1038/s41586-019-0966-0.

PMID:
30755740
2.

Genomic insights into the 2016-2017 cholera epidemic in Yemen.

Weill FX, Domman D, Njamkepo E, Almesbahi AA, Naji M, Nasher SS, Rakesh A, Assiri AM, Sharma NC, Kariuki S, Pourshafie MR, Rauzier J, Abubakar A, Carter JY, Wamala JF, Seguin C, Bouchier C, Malliavin T, Bakhshi B, Abulmaali HHN, Kumar D, Njoroge SM, Malik MR, Kiiru J, Luquero FJ, Azman AS, Ramamurthy T, Thomson NR, Quilici ML.

Nature. 2019 Jan;565(7738):230-233. doi: 10.1038/s41586-018-0818-3. Epub 2019 Jan 2. Erratum in: Nature. 2019 Feb;566(7745):E14.

3.

Integrated view of Vibrio cholerae in the Americas.

Domman D, Quilici ML, Dorman MJ, Njamkepo E, Mutreja A, Mather AE, Delgado G, Morales-Espinosa R, Grimont PAD, Lizárraga-Partida ML, Bouchier C, Aanensen DM, Kuri-Morales P, Tarr CL, Dougan G, Parkhill J, Campos J, Cravioto A, Weill FX, Thomson NR.

Science. 2017 Nov 10;358(6364):789-793. doi: 10.1126/science.aao2136.

PMID:
29123068
4.

Genomic history of the seventh pandemic of cholera in Africa.

Weill FX, Domman D, Njamkepo E, Tarr C, Rauzier J, Fawal N, Keddy KH, Salje H, Moore S, Mukhopadhyay AK, Bercion R, Luquero FJ, Ngandjio A, Dosso M, Monakhova E, Garin B, Bouchier C, Pazzani C, Mutreja A, Grunow R, Sidikou F, Bonte L, Breurec S, Damian M, Njanpop-Lafourcade BM, Sapriel G, Page AL, Hamze M, Henkens M, Chowdhury G, Mengel M, Koeck JL, Fournier JM, Dougan G, Grimont PAD, Parkhill J, Holt KE, Piarroux R, Ramamurthy T, Quilici ML, Thomson NR.

Science. 2017 Nov 10;358(6364):785-789. doi: 10.1126/science.aad5901.

PMID:
29123067
5.

Erratum: Global phylogeography and evolutionary history of Shigella dysenteriae type 1.

Njamkepo E, Fawal N, Tran-Dien A, Hawkey J, Strockbine N, Jenkins C, Talukder KA, Bercion R, Kuleshov K, Kolínská R, Russell JE, Kaftyreva L, Accou-Demartin M, Karas A, Vandenberg O, Mather AE, Mason CJ, Page AJ, Ramamurthy T, Bizet C, Gamian A, Carle I, Sow AG, Bouchier C, Wester AL, Lejay-Collin M, Fonkoua MC, Le Hello S, Blaser MJ, Jernberg C, Ruckly C, Mérens A, Page AL, Aslett M, Roggentin P, Fruth A, Denamur E, Venkatesan M, Bercovier H, Bodhidatta L, Chiou CS, Clermont D, Colonna B, Egorova S, Pazhani GP, Ezernitchi AV, Guigon G, Harris SR, Izumiya H, Korzeniowska-Kowal A, Lutyńska A, Gouali M, Grimont F, Langendorf C, Marejková M, Peterson LA, Perez-Perez G, Ngandjio A, Podkolzin A, Souche E, Makarova M, Shipulin GA, Ye C, Žemličková H, Herpay M, Grimont PA, Parkhill J, Sansonetti P, Holt KE, Brisse S, Thomson NR, Weill FX.

Nat Microbiol. 2016 Oct 3;1(11):16209. doi: 10.1038/nmicrobiol.2016.209. No abstract available.

PMID:
27694821
6.

Global phylogeography and evolutionary history of Shigella dysenteriae type 1.

Njamkepo E, Fawal N, Tran-Dien A, Hawkey J, Strockbine N, Jenkins C, Talukder KA, Bercion R, Kuleshov K, Kolínská R, Russell JE, Kaftyreva L, Accou-Demartin M, Karas A, Vandenberg O, Mather AE, Mason CJ, Page AJ, Ramamurthy T, Bizet C, Gamian A, Carle I, Sow AG, Bouchier C, Wester AL, Lejay-Collin M, Fonkoua MC, Le Hello S, Blaser MJ, Jernberg C, Ruckly C, Mérens A, Page AL, Aslett M, Roggentin P, Fruth A, Denamur E, Venkatesan M, Bercovier H, Bodhidatta L, Chiou CS, Clermont D, Colonna B, Egorova S, Pazhani GP, Ezernitchi AV, Guigon G, Harris SR, Izumiya H, Korzeniowska-Kowal A, Lutyńska A, Gouali M, Grimont F, Langendorf C, Marejková M, Peterson LA, Perez-Perez G, Ngandjio A, Podkolzin A, Souche E, Makarova M, Shipulin GA, Ye C, Žemličková H, Herpay M, Grimont PA, Parkhill J, Sansonetti P, Holt KE, Brisse S, Thomson NR, Weill FX.

Nat Microbiol. 2016 Mar 21;1:16027. doi: 10.1038/nmicrobiol.2016.27. Erratum in: Nat Microbiol. 2016 Oct 03;1(11):16209.

PMID:
27572446
7.

New Data on Vaccine Antigen Deficient Bordetella pertussis Isolates.

Bouchez V, Hegerle N, Strati F, Njamkepo E, Guiso N.

Vaccines (Basel). 2015 Sep 14;3(3):751-70. doi: 10.3390/vaccines3030751.

8.

Comparison of lipopolysaccharide structures of Bordetella pertussis clinical isolates from pre- and post-vaccine era.

Albitar-Nehme S, Basheer SM, Njamkepo E, Brisson JR, Guiso N, Caroff M.

Carbohydr Res. 2013 Aug 30;378:56-62. doi: 10.1016/j.carres.2013.05.002. Epub 2013 May 13.

PMID:
23731797
9.

Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009.

Advani A, Hallander HO, Dalby T, Krogfelt KA, Guiso N, Njamkepo E, von Könnig CH, Riffelmann M, Mooi FR, Sandven P, Lutynska A, Fry NK, Mertsola J, He Q.

J Clin Microbiol. 2013 Feb;51(2):422-8. doi: 10.1128/JCM.02036-12. Epub 2012 Nov 21.

10.

Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin.

Hegerle N, Paris AS, Brun D, Dore G, Njamkepo E, Guillot S, Guiso N.

Clin Microbiol Infect. 2012 Sep;18(9):E340-6. doi: 10.1111/j.1469-0691.2012.03925.x. Epub 2012 Jun 21.

11.

Prevalence of Bordetella pertussis and Bordetella parapertussis infections in Tunisian hospitalized infants: results of a 4-year prospective study.

Zouari A, Smaoui H, Brun D, Njamkepo E, Sghaier S, Zouari E, Félix R, Menif K, Ben Jaballah N, Guiso N, Kechrid A.

Diagn Microbiol Infect Dis. 2012 Apr;72(4):303-17. doi: 10.1016/j.diagmicrobio.2012.01.002. Epub 2012 Feb 6.

PMID:
22313629
12.

Significant finding of Bordetella holmesii DNA in nasopharyngeal samples from French patients with suspected pertussis.

Njamkepo E, Bonacorsi S, Debruyne M, Gibaud SA, Guillot S, Guiso N.

J Clin Microbiol. 2011 Dec;49(12):4347-8. doi: 10.1128/JCM.01272-11. Epub 2011 Oct 19.

13.

Bordetella petrii infection with long-lasting persistence in human.

Le Coustumier A, Njamkepo E, Cattoir V, Guillot S, Guiso N.

Emerg Infect Dis. 2011 Apr;17(4):612-8. doi: 10.3201/eid1704.101480.

14.

[The re-emergence of pertussis in Tunisia].

Zouari A, Smaoui H, Njamkepo E, Mnif K, Ben Jaballah N, Bousnina S, Barsaoui S, Sammoud A, Ben Becher S, Guiso N, Kechrid A.

Med Mal Infect. 2011 Feb;41(2):97-101. doi: 10.1016/j.medmal.2010.11.008. Epub 2011 Jan 6. French.

PMID:
21215539
15.

Monitoring of Bordetella isolates circulating in Saint Petersburg, Russia between 2001 and 2009.

Kurova N, Njamkepo E, Brun D, Tseneva G, Guiso N.

Res Microbiol. 2010 Dec;161(10):810-5. doi: 10.1016/j.resmic.2010.09.013. Epub 2010 Sep 24.

PMID:
20870020
16.

Bordetella parapertussis isolates not expressing pertactin circulating in France.

Bouchez V, Brun D, Dore G, Njamkepo E, Guiso N.

Clin Microbiol Infect. 2011 May;17(5):675-82. doi: 10.1111/j.1469-0691.2010.03303.x.

17.

Investigation on a pertussis outbreak in a military school: risk factors and approach to vaccine efficacy.

Berger F, Njamkepo E, Minaberry S, Mayet A, Haus-Cheymol R, Verret C, Massit B, Guiso N, Spiegel A.

Vaccine. 2010 Jul 19;28(32):5147-52. doi: 10.1016/j.vaccine.2010.05.070. Epub 2010 Jun 9. Review.

PMID:
20541009
18.

Type-IIA secreted phospholipase A2 is an endogenous antibiotic-like protein of the host.

Wu Y, Raymond B, Goossens PL, Njamkepo E, Guiso N, Paya M, Touqui L.

Biochimie. 2010 Jun;92(6):583-7. doi: 10.1016/j.biochi.2010.01.024. Epub 2010 Feb 6. Review.

PMID:
20144678
19.

First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin.

Bouchez V, Brun D, Cantinelli T, Dore G, Njamkepo E, Guiso N.

Vaccine. 2009 Oct 9;27(43):6034-41. doi: 10.1016/j.vaccine.2009.07.074. Epub 2009 Aug 8.

PMID:
19666155
20.

Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendations.

Launay O, Toneatti C, Bernède C, Njamkepo E, Petitprez K, Leblond A, Larnaudie S, Goujon C, Ungeheuer MN, Ajana F, Raccurt C, Beytout J, Chidiac C, Bouhour D, Guillemot D, Guiso N.

Hum Vaccin. 2009 May;5(5):341-6. Epub 2009 May 9.

PMID:
19221513
21.

Whole-cell pertussis vaccine induces low antibody levels in human immunodeficiency virus-infected children living in sub-Saharan Africa.

Tejiokem MC, Njamkepo E, Gouandjika I, Rousset D, Béniguel L, Bilong C, Tene G, Penda I, Ngongueu C, Gody JC, Guiso N, Baril L.

Clin Vaccine Immunol. 2009 Apr;16(4):479-83. doi: 10.1128/CVI.00312-08. Epub 2009 Feb 4.

22.

Genomic analysis and comparison of Bordetella pertussis isolates circulating in low and high vaccine coverage areas.

Njamkepo E, Cantinelli T, Guigon G, Guiso N.

Microbes Infect. 2008 Nov-Dec;10(14-15):1582-6. doi: 10.1016/j.micinf.2008.09.012. Epub 2008 Oct 17.

PMID:
18977453
23.

Pertussis surveillance in private pediatric practices, France, 2002-2006.

Guiso N, de La Rocque F, Njamkepo E, Lécuyer A, Levy C, Romain O, Thollot F, Abitbol V, Soubeyrand B, Cohen R; French Pediatrics Groups Association Clinique et Thérapeutique Infantile du Val de Marne and Association Française de Pédiatrie Ambulatoire.

Emerg Infect Dis. 2008 Jul;14(7):1159-61. doi: 10.3201/eid1407.071246. No abstract available.

24.

Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007.

André P, Caro V, Njamkepo E, Wendelboe AM, Van Rie A, Guiso N.

J Clin Microbiol. 2008 May;46(5):1672-7. doi: 10.1128/JCM.02187-07. Epub 2008 Mar 26.

25.

HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization.

Tejiokem MC, Gouandjika I, Béniguel L, Zanga MC, Tene G, Gody JC, Njamkepo E, Kfutwah A, Penda I, Bilong C, Rousset D, Pouillot R, Tangy F, Baril L.

PLoS One. 2007 Dec 5;2(12):e1260.

26.

Transmission of Bordetella pertussis to young infants.

Wendelboe AM, Njamkepo E, Bourillon A, Floret DD, Gaudelus J, Gerber M, Grimprel E, Greenberg D, Halperin S, Liese J, Muñoz-Rivas F, Teyssou R, Guiso N, Van Rie A; Infant Pertussis Study Group.

Pediatr Infect Dis J. 2007 Apr;26(4):293-9.

PMID:
17414390
27.

Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life.

Guiso N, Njamkepo E, Vié le Sage F, Zepp F, Meyer CU, Abitbol V, Clyti N, Chevallier S.

Vaccine. 2007 Feb 9;25(8):1390-7. Epub 2006 Nov 7.

PMID:
17134795
28.

Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies.

Caro V, Njamkepo E, Van Amersfoorth SC, Mooi FR, Advani A, Hallander HO, He Q, Mertsola J, Riffelmann M, Vahrenholz C, Von König CH, Guiso N.

Microbes Infect. 2005 Jun;7(7-8):976-82.

PMID:
15994109
29.

Analysis of Bordetella pertussis populations in European countries with different vaccination policies.

van Amersfoorth SC, Schouls LM, van der Heide HG, Advani A, Hallander HO, Bondeson K, von König CH, Riffelmann M, Vahrenholz C, Guiso N, Caro V, Njamkepo E, He Q, Mertsola J, Mooi FR.

J Clin Microbiol. 2005 Jun;43(6):2837-43.

30.

Nosocomial pertussis outbreak among adult patients and healthcare workers.

Bassinet L, Matrat M, Njamkepo E, Aberrane S, Housset B, Guiso N.

Infect Control Hosp Epidemiol. 2004 Nov;25(11):995-7.

PMID:
15566036
31.

Characterization of adenylate cyclase-hemolysin gene duplication in a Bordetella pertussis isolate.

Dalet K, Weber C, Guillemot L, Njamkepo E, Guiso N.

Infect Immun. 2004 Aug;72(8):4874-7.

32.

Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a french area with very high whole-cell vaccine coverage.

Gilberg S, Njamkepo E, Du Châtelet IP, Partouche H, Gueirard P, Ghasarossian C, Schlumberger M, Guiso N.

J Infect Dis. 2002 Aug 1;186(3):415-8. Epub 2002 Jul 11.

PMID:
12134239
33.

Thirty-five years' experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity.

Njamkepo E, Rimlinger F, Thiberge S, Guiso N.

Vaccine. 2002 Jan 31;20(9-10):1290-4.

PMID:
11818147
34.

Bordetella holmesii isolated from a patient with sickle cell anemia: analysis and comparison with other Bordetella holmesii isolates.

Njamkepo E, Delisle F, Hagege I, Gerbaud G, Guiso N.

Clin Microbiol Infect. 2000 Mar;6(3):131-6.

35.

Adaptive responses of human monocytes infected by bordetella pertussis: the role of adenylate cyclase hemolysin.

Njamkepo E, Pinot F, François D, Guiso N, Polla BS, Bachelet M.

J Cell Physiol. 2000 Apr;183(1):91-9.

PMID:
10699970
36.

Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination.

Baron S, Njamkepo E, Grimprel E, Begue P, Desenclos JC, Drucker J, Guiso N.

Pediatr Infect Dis J. 1998 May;17(5):412-8.

PMID:
9613656
37.

Rapid diagnosis of pertussis in young infants: comparison of culture, PCR, and infant's and mother's serology.

Grimprel E, Njamkepo E, Bégué P, Guiso N.

Clin Diagn Lab Immunol. 1997 Nov;4(6):723-6.

38.

Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France.

Grimprel E, Bégué P, Anjak I, Njamkepo E, François P, Guiso N.

Clin Diagn Lab Immunol. 1996 Jan;3(1):93-7.

39.

Selective processing of submandibular rat 1 protein at dibasic cleavage sites. Salivary and bloodstream secretion products.

Rougeot C, Rosinski-Chupin I, Njamkepo E, Rougeon F.

Eur J Biochem. 1994 Feb 1;219(3):765-73.

Supplemental Content

Loading ...
Support Center